BILLS-107hr4013ih.pdf
House Resolutions
0 pages
Page
of 0
Loading OCR text...
No OCR text available for this page.
Failed to load OCR text.
DATE (11)
the fiscal years 2003 through 2006
fiscal year 2002
the 1970s
1993
5 years
biennially
annual
2
2002
MARCH 20, 2002
many years
1983
EVENT (2)
the ‘‘Rare Diseases Act
SESSION
H. R. 4013
GPE (5)
the United States
Huntington
the United States of America
United States
Ohio
NORP (1)
Americans
ORG (36)
Institutes of Health
the Public Health Service Act
National
SEC
NIH
Congress
Office
U.S.C.
Health
the National Institutes of Health
an Office of Rare Diseases
Committee
An Orphan Products Board
an Office of Rare
Diseases
the Office of the Director
the National Institutes of
Health
House of Representa-
NIH OFFICE OF RARE
Energy and Commerce
the National Organization for Rare Disorders
2
Rare Diseases
the ‘Office’
Health and Human Services
LENCE
Department
THE HOUSE OF REPRESENTATIVES
Senate
tional Institutes of Health
the Office of Rare Diseases
the Food and Drug Admin-
the Food and Drug Administra-
NORD
New Federal
PERSON (12)
RUSH
Lou Gehrig’s
KING
FOLEY
BROWN
GREENWOOD
WAXMAN
Duchenne
13
Crohn
ROUKEMA
SHIMKUS
Orphan
Topic Classifications
congressional legislation
92.0%
public health
47.4%
government oversight
31.2%
Extracted Keywords
rare diseases
rare
office rare
diseases
orphan
diseases disorders
disorders
orphan drugs
institutes
institutes health
national institutes
drug act
drugs
research
orphan drug
Forensic Analysis
PDF Metadata
- ModDate
- D:20230115143758Z
- Producer
- Acrobat Distiller 4.0 for Windows; modified using iText® Core 7.2.3 (production version) ©2000-2022 iText Group NV, Government Publishing Office
- CreationDate
- D:20020325125912Z
Sentiment
Polarity
Positive
0.152
Subjectivity
55%
Subjective